mRNA vaccines: Four major clinical trial readouts to watch in 2023
After their success in Covid-19, can mRNA vaccines breakthrough in influenza, herpes, and even cancer?
Predictive analytics in drug development: state of play
Inclusive drugs: designing clinical trials for the pregnant population
Five gene therapy trial readouts to watch in the first half of 2023
Renexxion reveals clinical development plans to address GI symptoms in cystic fibrosis patients
Pipeline Moves: Trial completion bumps advancement prospects for AstraZeneca’s oncology drug
Analysis
View More
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Themes
View MoreGreenLight receives Rwanda FDA approval for Covid-19 mRNA vaccine trial
The Phase I/II clinical trial will evaluate the safety and immunogenicity of the vaccine.
More themes
Insights
View MoreWho’s hiring who? Hiring activity related to social responsibility increased by 10% in the pharmaceutical industry in Q3 2022
The global pharmaceutical industry experienced a 10% rise in new job postings related to social responsibility in Q3 2022 compared…
Dyadic initiates subject dosing in Phase I trial of Covid-19 booster
Tevogen Bio reports positive data from Covid-19 T cell therapy trial
Cyrano to initiate Phase II trial of nasal spray therapy for Hyposmia
Shionogi commences Phase I/II/III and Phase III trials of Covid-19 vaccine